ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACHV
DatumZeitQuelleÜberschriftSymbolFirma
29/01/202420h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202400h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
25/01/202400h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
11/12/202322h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
09/11/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
26/10/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023NASDAQ:ACHVAchieve Life Sciences Inc
03/10/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
11/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
07/09/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
14/08/202322h00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
01/08/202314h00GlobeNewswire Inc.Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and WebcastNASDAQ:ACHVAchieve Life Sciences Inc
18/07/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
11/07/202317h23GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)NASDAQ:ACHVAchieve Life Sciences Inc
26/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHVAchieve Life Sciences Inc
09/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHVAchieve Life Sciences Inc
06/06/202314h00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ACHV
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Support: +44 (0) 203 8794 460 | support@advfn.de